Significant progress in chikungunya Control: FDA approval of Ixchiq vaccine

• Shriyansh Srivastava,
• Sachin Kumar,
• Prakasini Satapathy,
• Kadhim Hussein Jaaaim,
• Alaa Hamza Hermis,
• Rachana Mehta,
• Ranjit Sah

Affiliations

Shriyansh Srivastava

Corresponding author.; Department of Pharmacology, Delhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi 273007, India; Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, India

Sachin Kumar

Department of Pharmacology, Delhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi 273007, India

Prakasini Satapathy

Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India

Kadhim Hussein Jaaaim

Nursing College, AI-Mustaqbal University, 51001 Hillah, Babylon, Iraq

Alaa Hamza Hermis

Nursing College, AI-Mustaqbal University, 51001 Hillah, Babylon, Iraq

Rachana Mehta

Corresponding author.; National Public Health Laboratory, Kathmandu, Nepal

Ranjit Sah

Tribhuvan University Teaching Hospital, Kathmandu 46000, Nepal; Department of Clinical Microbiology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune 411000, Maharashtra, India; Department of Public Health Dentistry, Dr. D.Y. Patil Dental College and Hospital, Dr. D.Y. Patil Vidyapeeth, Pune 411018, Maharashtra, India